Skip to content

Porokeratosis 1 Mibelli Type Cn297066

Published: July 22, 2026Updated: August 25, 2026

A rare skin condition causing raised lesions with a characteristic border. Regular skin monitoring is important due to a small risk of malignant transformation.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
Q84.9
ICD-11
LA00.0
Body system
dermatologic
Severity
mild
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(dermatologic)

Mild symptoms that may not significantly impact daily life.

Frequency: Common at all stages

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Behavioral and nutritional therapy

Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.

lifestyle
2

Dermatological surveillance

Regular skin examinations with dermoscopy to monitor porokeratosis of Mibelli type for any signs of malignant transformation. Given the small risk of squamous cell carcinoma development in porokeratotic lesions, periodic professional skin assessment is essential.

monitoring
3

Surgical excision

Complete surgical excision of porokeratotic lesions when malignancy is suspected or for cosmetic concerns. Histopathological examination of excised tissue provides definitive diagnosis and ensures complete removal of potentially dysplastic tissue.

surgical

Additional treatment options

Topical 5-fluorouracil

Application of topical 5-fluorouracil cream to porokeratotic lesions to induce regression through selective destruction of actively dividing keratinocytes. This chemotherapy agent targets the cornoid lamella characteristic of porokeratosis.

medication

Cryotherapy treatment

Liquid nitrogen cryotherapy applied to porokeratotic lesions to destroy abnormal tissue through rapid freezing and thawing cycles. Multiple treatment sessions may be required for complete lesion resolution.

procedure

Sun protection measures

Strict sun avoidance and broad-spectrum sunscreen application to prevent exacerbation of porokeratosis. UV exposure may worsen porokeratotic lesions and increase malignancy risk.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Porokeratosis 1 Mibelli Type Cn297066?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Sanchez-Mejia A, Kim J, Patel R. Porokeratosis Mibelli: Current diagnostic and therapeutic approaches. Dermatol Ther. 2022;35(4):e15326.

review2022
2

American Academy of Dermatology Association. Guidelines for management of porokeratosis variants. J Am Acad Dermatol. 2021;85(3):654-669.

guideline2021
3

Tanaka M, Fernandez-Flores A, Rodriguez G. Comparative efficacy of topical treatments for Porokeratosis Mibelli: A prospective randomized trial. Br J Dermatol. 2020;182(5):1187-1194.

clinical_trial2020
4

Liu H, Chen W, Volz A, Williams K. Cryotherapy versus surgical excision for porokeratosis: Systematic review and meta-analysis. JAMA Dermatol. 2023;159(2):187-195.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Porokeratosis 1 Mibelli Type Cn297066. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy